The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s GSA Schedule contract for pharmaceuticals and drugs. The order is for ICLUSIG 15 MG to be delivered to the VA medical center in Earth City, Missouri by December 12, 2023. Takeda Pharmaceutical Company LIMITED is the parent company of Takeda Pharmaceuticals America, Inc., the prime contractor performing under the firm-fixed price contract. The funding...
Takeda Pharmaceuticals America, Inc. has been awarded a $27,913.44 delivery order against its multiple-award Government Services Administration (GSA) Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The order is for ICLUSIG 15MG tablets to be delivered to a place of performance in Earth City, Missouri by April 12, 2024. The contract utilizes a firm fixed price payment...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $13,956.72 firm fixed price delivery order contract to Takeda Pharmaceuticals America, Inc. for ICLUSIG 15 MG. The contract was awarded on January 25, 2024 and is to be completed by January 30, 2024. It utilizes the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract vehicle, with performance taking place in Earth City, Missouri. Takeda Pharmaceuticals...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. This firm fixed price order is to supply ICLUSIG 15 MG tablets to the VA Veterans Integrated Service Network 5 facility in Earth City, Missouri, with performance from June 27 through 30, 2023. As the parent company, Takeda Pharmaceutical Company LIMITED backs Takeda Pharmaceuticals...
The Department of Veterans Affairs Veterans Health Administration awarded a $13,043 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract number 61-IB. The order is for ICLUSIG 15 MG tablets to be delivered to the VA medical center in Earth City, Missouri by September 6, 2023. As the parent of Takeda Pharmaceuticals America, Takeda Pharmaceutical Company LIMITED may support order fulfillment. The funding agency, VHA Network 5, will...
The Department of Veterans Affairs Veterans Health Administration awarded a $26,086.86 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract. Takeda will provide EMERGENT ICLUSIG PHARM ORDER to the Veterans Integrated Service Network 20 in Cambridge, Massachusetts under a firm fixed price contract running from November 2023 through May 2024. As the parent company of Takeda Pharmaceuticals America, Takeda Pharmaceutical Company...
The Department of Veterans Affairs Veterans Health Administration awarded a $14,330.88 delivery order contract to Takeda Pharmaceuticals America, Inc. for the pharmaceutical ICLUSIG 30 MG. Takeda Pharmaceuticals America is a subsidiary of Takeda Pharmaceutical Company LIMITED and will supply the product under GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB). Performance will take place in Earth City, Missouri over a period of five days from October 26 to October 30, 2023. The fixed-price...
The Department of Veterans Affairs Veterans Health Administration awarded a $26,086.86 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract. Takeda will provide EMERGENT ICLUSIG PHARM ORDER to Veterans Integrated Service Network 20 in Cambridge, Massachusetts over a period of performance from December 12, 2023 through February 29, 2024 under firm fixed pricing terms. As the prime contractor, Takeda Pharmaceuticals America is a...
The Department of Veterans Affairs Veterans Health Administration awarded a $14,330.88 delivery order contract to Takeda Pharmaceuticals America, Inc. for the pharmaceutical ICLUSIG 30 MG. Takeda Pharmaceutical Company LIMITED is the parent company of the prime contractor. The contract was awarded against Takeda's Pharmaceuticals and Drugs GSA Schedule contract and will be performed in Earth City, Missouri over a four-day period from September 26-29, 2023. As the contract was awarded on a firm...
This federal contract award is for the delivery of ICLUSIG 45MG TABLET and ICLUSIG 15MG TABLET pharmaceuticals to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $197,695.41 contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. Takeda Pharmaceuticals America is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited. The contract was awarded as...